<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药智网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-12T20:43:23+08:00</updated>
  <subtitle>一个有态度、有深度、有温度的医药健康领域融媒体平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>百济神州研发不止会“烧钱”也会“挣”，PD-1联手诺华进军“发达国家”</title>
    <updated>2021-01-12T17:26:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/XmsMQcbL8bS3r2lHfXx5Qg</id>
    <link href="https://mp.weixin.qq.com/s/XmsMQcbL8bS3r2lHfXx5Qg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>200亿血友病蓝海，国产重组凝血因子VIII即将实现“0”的突破</title>
    <updated>2021-01-12T17:26:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/xzZiNAJxuyCiFd_hj3k-LQ</id>
    <link href="https://mp.weixin.qq.com/s/xzZiNAJxuyCiFd_hj3k-LQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年第一集采来了！8省区，17品种纳入（附名单）</title>
    <updated>2021-01-12T17:26:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/doMjgZrT_pDiVyBWbhSE6g</id>
    <link href="https://mp.weixin.qq.com/s/doMjgZrT_pDiVyBWbhSE6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刘昌孝：双循环战略促进后新冠疫情时期的生物医药创新发展</title>
    <updated>2021-01-12T17:26:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/jbeOctGVotZhBMU6jgLRRA</id>
    <link href="https://mp.weixin.qq.com/s/jbeOctGVotZhBMU6jgLRRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点:「化药1类」进口IND品种分析，罗氏、诺华、百济、信达…</title>
    <updated>2021-01-11T16:52:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/aNxl-GsCqkTBMaB_Ofxtyw</id>
    <link href="https://mp.weixin.qq.com/s/aNxl-GsCqkTBMaB_Ofxtyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药企老司机安进(Amgen)，研发管线布局有何特别之处？</title>
    <updated>2021-01-11T16:52:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/yGvKDyPlJGwp7HwcrEJPHw</id>
    <link href="https://mp.weixin.qq.com/s/yGvKDyPlJGwp7HwcrEJPHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>知名药企，裁撤销售团队</title>
    <updated>2021-01-11T16:52:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/kI30J-wuutHB8A_VjzZTUA</id>
    <link href="https://mp.weixin.qq.com/s/kI30J-wuutHB8A_VjzZTUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>当心“新冠疫苗预约”骗局！这份指南收好</title>
    <updated>2021-01-11T16:52:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/r1CmsaV7GMPf1b7b8KrzVQ</id>
    <link href="https://mp.weixin.qq.com/s/r1CmsaV7GMPf1b7b8KrzVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【药咖君】恒瑞阿帕替尼获批肝癌适应症！国内迎来乳腺癌新药，天士力、礼来、默沙东…</title>
    <updated>2021-01-10T10:08:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/0q4D04ERhIOJa5pJxh9wcA</id>
    <link href="https://mp.weixin.qq.com/s/0q4D04ERhIOJa5pJxh9wcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>春天里的“寒冬”？医药行业会长解读2021年市场新趋势</title>
    <updated>2021-01-09T10:01:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/UPcOT22c-B_prdVETkY3Pg</id>
    <link href="https://mp.weixin.qq.com/s/UPcOT22c-B_prdVETkY3Pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【好药记】注射剂扎堆过评，人福药业5款重磅麻醉药品在内；多企业多品种争相通过，正大天晴、豪森、扬子江...</title>
    <updated>2021-01-08T17:01:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/2BfXKp7mo7TGr2vFJ2BYGw</id>
    <link href="https://mp.weixin.qq.com/s/2BfXKp7mo7TGr2vFJ2BYGw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点：高瓴资本“生物医药”布局有何变化，投资逻辑究竟是啥？</title>
    <updated>2021-01-08T17:01:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/A39S-c6q_AnGRYjtOwxUEg</id>
    <link href="https://mp.weixin.qq.com/s/A39S-c6q_AnGRYjtOwxUEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从闪亮登场到鲜有问津，基本药物制度走进迷宫</title>
    <updated>2021-01-08T17:01:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/4811jyXh7Xz_LCFWZXoMSA</id>
    <link href="https://mp.weixin.qq.com/s/4811jyXh7Xz_LCFWZXoMSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>曝光台 | 一周内两次“上榜” 亳州中强现已停产</title>
    <updated>2021-01-08T17:01:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/AkKt3b2es6NapJcH30f_ZQ</id>
    <link href="https://mp.weixin.qq.com/s/AkKt3b2es6NapJcH30f_ZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020上市药企涨幅TOP10！最高涨幅1500%，CRO、疫苗或将再涨3年</title>
    <updated>2021-01-07T17:15:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/fLWZLz-V45NsD8PWbnPGog</id>
    <link href="https://mp.weixin.qq.com/s/fLWZLz-V45NsD8PWbnPGog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>银屑病药物市场增长迅速，古塞库人单抗占比1/4，较去年“翻了个倍”</title>
    <updated>2021-01-07T17:15:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/DmzdH8LDje6aQ9K2x09qKA</id>
    <link href="https://mp.weixin.qq.com/s/DmzdH8LDje6aQ9K2x09qKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年终回馈 | 所有的感谢，都在“礼”面</title>
    <updated>2021-01-07T17:15:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/_ryL5W4QVPANUtJ7354TbA</id>
    <link href="https://mp.weixin.qq.com/s/_ryL5W4QVPANUtJ7354TbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞、梯瓦、GSK等制药巨头2021上调药价</title>
    <updated>2021-01-07T17:15:54+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/9L8O-Dbygp8lt308jY5JQg</id>
    <link href="https://mp.weixin.qq.com/s/9L8O-Dbygp8lt308jY5JQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点：重庆市药品审评分析！位列全国药品申报量top17，福安、北大医药、圣华曦…</title>
    <updated>2021-01-06T16:52:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/Z7Syizrguzzj_dbu_MHiNA</id>
    <link href="https://mp.weixin.qq.com/s/Z7Syizrguzzj_dbu_MHiNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>200亿长效生长激素市场，“王者争霸”，谁将独领风骚？</title>
    <updated>2021-01-06T16:52:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/rVbmUbON3jdbYSjJRCVOIQ</id>
    <link href="https://mp.weixin.qq.com/s/rVbmUbON3jdbYSjJRCVOIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>